Jalal Abdolalizadeh
Overview
Explore the profile of Jalal Abdolalizadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
68
Citations
615
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zununi Vahed S, Zuluaga Tamayo M, Rodriguez-Ruiz V, Thibaudeau O, Aboulhassanzadeh S, Abdolalizadeh J, et al.
Pharmaceutics
. 2024 Jul;
16(7).
PMID: 39065537
It was previously reported that crocin, a water-soluble carotenoid isolated from the L. (saffron), has protective effects on cardiac cells and may neutralize and even prevent the formation of excess...
2.
Hoseinpour R, Hasani A, Baradaran B, Abdolalizadeh J, Salehi R, Hasani A, et al.
Heliyon
. 2024 Feb;
10(4):e26193.
PMID: 38404880
Despite the widespread use of the Bacillus Calmette-Guérin (BCG) vaccine, (MTB) continues to be a global burden. Vaccination has been proposed to prevent and treat tuberculosis (TB) infection, and several...
3.
Raeisi H, Azimirad M, Aghdaei H, Zarnani A, Abdolalizadeh J, Yadegar A, et al.
Microbiol Spectr
. 2023 Sep;
:e0531022.
PMID: 37668373
TcdA and TcdB are known as the major virulence attributes of . Hence, neutralizing the TcdA and TcdB activities can be considered as an efficient therapeutic approach against infection (CDI)....
4.
Hoseinpur R, Hasani A, Baradaran B, Abdolalizadeh J, Amini Y, Salehi R, et al.
J Biomater Appl
. 2022 Apr;
37(1):40-47.
PMID: 35430919
This study attempted to explore the immunogenicity of chitosan nanoparticles containing fusion protein (Hspx-PPE44-EsxV; HPE) and resiquimod adjuvant (HPERC) in BALB/c mice. HPE was initially expressed in BL21 cells. HPE...
5.
Shakouri A, Kahroba H, Hamishekar H, Abdolalizadeh J
Bioimpacts
. 2022 Apr;
12(2):115-126.
PMID: 35411300
Breast cancer is the most serious cause of women's death throughout the world. Using nanocarrier vehicles to the exact site of cancer upgrades the therapeutic efficiency of the drugs. Capsulation...
6.
Masoumi J, Jafarzadeh A, Abdolalizadeh J, Khan H, Philippe J, Mirzaei H, et al.
Acta Pharm Sin B
. 2021 Aug;
11(7):1721-1739.
PMID: 34386318
Cancer stem cells (CSCs) with their self-renewal ability are accepted as cells which initiate tumors. CSCs are regarded as interesting targets for novel anticancer therapeutic agents because of their association...
7.
Sambrani R, Abdolalizadeh J, Kohan L, Jafari B
Mol Biol Rep
. 2021 Jan;
48(1):951-960.
PMID: 33389533
Today, the increasing rate of cancer-related mortality, has rendered cancer a major global challenge, and the second leading cause of death worldwide. Conventional approaches in the treatment of cancer mainly...
8.
Vostakolaei M, Hatami-Baroogh L, Babaei G, Molavi O, Kordi S, Abdolalizadeh J
J Cell Physiol
. 2020 Nov;
236(5):3420-3444.
PMID: 33169384
The heat shock protein (Hsps) superfamily, also known as molecular chaperones, are highly conserved and present in all living organisms and play vital roles in protein fate. The HspA1A (Hsp70-1),...
9.
Malekghasemi S, Majidi J, Baghbanzadeh A, Abdolalizadeh J, Baradaran B, Aghebati-Maleki L
Adv Pharm Bull
. 2020 Oct;
10(4):556-565.
PMID: 33062602
Tumor microenvironment consists of malignant and non-malignant cells. The interaction of these dynamic and different cells is responsible for tumor progression at different levels. The non-malignant cells in TME contain...
10.
Sobati S, Shakouri A, Edalati M, Mohammadnejad D, Parvan R, Masoumi J, et al.
Adv Pharm Bull
. 2020 Oct;
10(4):502-511.
PMID: 33062601
Proprotein convertase subtilisin/kexin type 9 (PCSK9), as a vital modulator of low-density lipoprotein cholesterol (LDL-C) , is raised in hepatocytes and released into plasma where it binds to LDL receptors...